COPHF Stock - Creso Pharma Limited
Unlock GoAI Insights for COPHF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $18.92M | $8.69M | $6.22M | $2.45M | $3.63M |
| Gross Profit | $2.33M | $287,000 | $-400,611 | $-3,882,415 | $2.13M |
| Gross Margin | 12.3% | 3.3% | -6.4% | -158.6% | 58.6% |
| Operating Income | $-16,680,000 | $-19,567,000 | $-28,324,635 | $-16,839,283 | $-10,208,825 |
| Net Income | $-52,446,000 | $-32,782,000 | $-31,765,746 | $-37,577,192 | $-17,053,384 |
| Net Margin | -277.2% | -377.3% | -510.8% | -1535.2% | -470.3% |
| EPS | $0.00 | $-0.02 | $-0.03 | $-0.10 | $-0.12 |
Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
Visit WebsiteEarnings History & Surprises
COPHFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 30, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Oct 21, 2024 | — | — | — | — |
Q3 2024 | Aug 29, 2024 | — | — | — | — |
Q2 2024 | Apr 30, 2024 | — | — | — | — |
Q1 2024 | Feb 29, 2024 | — | — | — | — |
Q2 2023 | Jun 30, 2023 | — | $-5.18 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-6.87 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.04 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.02 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.03 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.03 | — | — |
Q3 2017 | Aug 28, 2017 | — | $-0.03 | — | — |
Q1 2017 | Feb 28, 2017 | — | $-0.03 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.03 | — | — |
Q1 2016 | Jan 31, 2016 | — | $-0.03 | — | — |
Latest News
Frequently Asked Questions about COPHF
What is COPHF's current stock price?
What is the analyst price target for COPHF?
What sector is Creso Pharma Limited in?
What is COPHF's market cap?
Does COPHF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to COPHF for comparison